These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 8195653)

  • 1. Intravenous immunoglobulin: implications for use in the neurological patient.
    Chipps E; Skinner C
    J Neurosci Nurs; 1994 Feb; 26(1):8-17. PubMed ID: 8195653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous immunoglobulin and autoimmune disease.
    El-Shanawany T; Jolles S
    Ann N Y Acad Sci; 2007 Sep; 1110():507-15. PubMed ID: 17911466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose intravenous immunoglobulins: an approach to treat severe immune-mediated and autoimmune diseases of the skin.
    Rütter A; Luger TA
    J Am Acad Dermatol; 2001 Jun; 44(6):1010-24. PubMed ID: 11369915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous immunoglobulin treatment of neurological autoimmune diseases.
    Stangel M; Hartung HP; Marx P; Gold R
    J Neurol Sci; 1998 Jan; 153(2):203-14. PubMed ID: 9511879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous immunoglobulin therapy in dermatologic disorders.
    Cakmak SK; Gül U; Gönül M; Kiliç A; Soylu S
    Inflamm Allergy Drug Targets; 2008 Jun; 7(2):75-84. PubMed ID: 18691136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 10% liquid human immunoglobulin (KIOVIG(®)) for immunomodulation in autoimmune disorders.
    Nikolov N; Reisinger J; Schwarz HP
    Immunotherapy; 2016 Jul; 8(8):923-40. PubMed ID: 27126341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of intravenous immunoglobulin G in autoimmune hematologic disorders.
    Blanchette VS; Kirby MA; Turner C
    Semin Hematol; 1992 Jul; 29(3 Suppl 2):72-82. PubMed ID: 1509297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug Insight: the use of intravenous immunoglobulin in neurology--therapeutic considerations and practical issues.
    Gold R; Stangel M; Dalakas MC
    Nat Clin Pract Neurol; 2007 Jan; 3(1):36-44. PubMed ID: 17205073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basic principles of intravenous immunoglobulin (IVIg) treatment.
    Stangel M; Pul R
    J Neurol; 2006 Sep; 253 Suppl 5():V18-24. PubMed ID: 16998749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous immunoglobulin preparations and autoimmune disorders: mechanisms of action.
    Ibáñez C; Montoro-Ronsano JB
    Curr Pharm Biotechnol; 2003 Aug; 4(4):239-47. PubMed ID: 14529426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adoptive-transfer effects of intravenous immunoglobulin in autoimmunity.
    Lazarus AH
    J Clin Immunol; 2010 May; 30 Suppl 1():S20-3. PubMed ID: 20401687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous immunoglobulins induce potentially synergistic immunomodulations in autoimmune disorders.
    Imbach P; Lazarus AH; Kühne T
    Vox Sang; 2010 Apr; 98(3 Pt 2):385-94. PubMed ID: 19821958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunomodulation with intravenous immunoglobulin.
    Hall PD
    Pharmacotherapy; 1993; 13(6):564-73. PubMed ID: 8302679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of action of intravenous immunoglobulin and therapeutic considerations in the treatment of autoimmune neurologic diseases.
    Dalakas MC
    Neurology; 1998 Dec; 51(6 Suppl 5):S2-8. PubMed ID: 9851723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous immunoglobulins in autoimmune and inflammatory diseases: a mechanistic perspective.
    Sibéril S; Elluru S; Graff-Dubois S; Negi VS; Delignat S; Mouthon L; Lacroix-Desmazes S; Kazatchkine MD; Bayry J; Kaveri SV
    Ann N Y Acad Sci; 2007 Sep; 1110():497-506. PubMed ID: 17911465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoregulation of autoimmune disorders: the role of intravenous immunoglobulins.
    Luzi G; Ferrara R
    Int J Artif Organs; 1993 Dec; 16 Suppl 5():189-95. PubMed ID: 8013987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous immunoglobulin (IVIg) in the treatment of autoimmune and inflammatory diseases.
    Ruiz de Souza V; Kaveri SV; Kazatchkine MD
    Clin Exp Rheumatol; 1993; 11 Suppl 9():S33-6. PubMed ID: 8354005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of IVIG in neurological disease.
    Levinson AI
    Clin Rev Allergy; 1992; 10(1-2):119-34. PubMed ID: 1318773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IVIG-mediated effector functions in autoimmune and inflammatory diseases.
    Galeotti C; Kaveri SV; Bayry J
    Int Immunol; 2017 Dec; 29(11):491-498. PubMed ID: 28666326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of intravenous immunoglobulin action in immune thrombocytopenic purpura.
    Jin F; Balthasar JP
    Hum Immunol; 2005 Apr; 66(4):403-10. PubMed ID: 15866704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.